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Abstract
Background: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life threatening clinical conditions
seen in critically ill patients with diverse underlying illnesses. Lung injury may be perpetuated by ventilation strategies that
do not limit lung volumes and airway pressures. We conducted a systematic review and meta-analysis of randomized
controlled trials (RCTs) comparing pressure and volume-limited (PVL) ventilation strategies with more traditional mechanical
ventilation in adults with ALI and ARDS.
Methods and Findings: We searched Medline, EMBASE, HEALTHSTAR and CENTRAL, related articles on PubMed
TM,
conference proceedings and bibliographies of identified articles for randomized trials comparing PVL ventilation with
traditional approaches to ventilation in critically ill adults with ALI and ARDS. Two reviewers independently selected trials,
assessed trial quality, and abstracted data. We identified ten trials (n=1,749) meeting study inclusion criteria. Tidal volumes
achieved in control groups were at the lower end of the traditional range of 10–15 mL/kg. We found a clinically important
but borderline statistically significant reduction in hospital mortality with PVL [relative risk (RR) 0.84; 95% CI 0.70, 1.00;
p=0.05]. This reduction in risk was attenuated (RR 0.90; 95% CI 0.74, 1.09, p=0.27) in a sensitivity analysis which excluded 2
trials that combined PVL with open-lung strategies and stopped early for benefit. We found no effect of PVL on barotrauma;
however, use of paralytic agents increased significantly with PVL (RR 1.37; 95% CI, 1.04, 1.82; p=0.03).
Conclusions: This systematic review suggests that PVL strategies for mechanical ventilation in ALI and ARDS reduce
mortality and are associated with increased use of paralytic agents.
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Introduction
Acute lung injury (ALI) and its most severe form, acute
respiratory distress syndrome (ARDS), are common life-threaten-
ing complications of critical illness. While support with mechanical
ventilation is crucial for survival, use of ventilators without regard
for lung volumes and airway pressures may perpetuate lung injury
and contribute to the associated high mortality of these clinical
conditions. Despite recent randomized controlled trials (RCTs),
the benefit of current ventilation strategies designed to limit
iatrogenic lung injury remains controversial.
In 1964, Greenfield et al proposed that mechanical ventilation
can induce lung injury. [1] Subsequent laboratory investigations
established a direct relationship between exposure to increasing
tidal volumes and airway pressures, and the development of
pulmonary lesions identical to those that characterize ARDS. [2,3]
These findings are consistent across species and in various models
of ARDS. [4] One proposed mechanism of injury includes
selective over-distention of the diminished volume of functional
lung tissue in ARDS. [5] Supporting these preclinical findings,
early clinical observations suggested that ventilation strategies to
reduce tidal volumes and airway pressures could improve survival.
[6–8].
These observations challenged the conventional primary goal of
mechanical ventilation, which was to achieve normal arterial
blood gas values. Accordingly, clinicians used tidal volumes in the
range of 10–15 mL/kg with no particular restrictions of airway
pressures. [9] In 1993, a Consensus Conference of experts
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that plateau airway pressures should not exceed 35 cm H2O and
tidal volumes could be reduced to 5 mL/kg or less to achieve this
pressure threshold, even if hypercapnia ensued [10]. The most
notable physiological effect of this approach is respiratory acidosis,
which can be associated with air hunger, agitation, and patient-
ventilator asynchrony, [11] hemodynamic compromise, and acute
kidney injury, although evidence for the latter effects is limited.
[12].
Several RCTs and meta-analyses [13–16] exploring the role for
pressure and volume-limited (PVL) ventilation strategies in ALI
and ARDS diverged in their conclusions. One systematic review of
6 trials involving 1297 patients concluded that PVL reduces
mortality at 28 days and at hospital discharge. [16] In contrast, an
analysis of 5 trials involving 1,202 patients concluded that ‘‘low
tidal volumes should not be standard for these patients.’’ [13]
Additional trials have been published since these reports. Our
objective was to systematically review all RCTs comparing PVL to
more traditional ventilation strategies for adults with ALI and
ARDS to clarify the effects on mortality and other relevant
outcomes, and to explore differences among study results.
Methods
We conducted this review according to current standards for sys-
tematic review and meta-analysis, [17] using a predefined protocol.
Search Strategy
We electronically searched Medline (1966-July 2010), EMBASE
(1980-July 2010), HEALTHSTAR (1975-July 2010), and CEN-
TRAL (to July 2010) without language restrictions, and hand-
searched abstracts published in the American Journal of Respiratory and
Critical Care Medicine, Chest, Intensive Care Medicine and Critical Care
Medicine (1995–2006). We also screened the reference lists,
searched the related articles feature on PubMed
TM, and contacted
investigators on each trial selected for review.
Trial Selection
Reviewers (KB, NA, MM) independently screened all titles and
abstracts in duplicate (except conference proceedings) and then the
full articles of all potentially relevant citations. We selected RCTs
including critically ill patients, of which at least 80% were adults,
at least 80% were mechanically ventilated, and at least 80% had
ALI (using author’s definitions). We resolved disagreements by
consensus.
Conceptually, we were interested in trials comparing ventilation
strategies that differed with respect to tidal volumes, airway
pressures, or both. Therefore, in addition to trials comparing
ventilation strategies with explicit constraints on tidal volumes or
airway pressures, we also considered trials that observed an
incidental gradient in tidal volume (at least 3 mL/kg) or plateau
pressure (at least 5 cm H2O) during the first 7 days of study. We
included trials that reported on mortality, barotrauma, duration of
mechanical ventilation, use of sedation or paralytic agents, need
for acute dialysis, or non-pulmonary organ dysfunction. We ex-
cluded quasi-randomized trials, such as those assigning patients by
alternate allocation or hospital file number, and trials evaluating
high frequency ventilation or oscillation, extracorporeal circula-
tion, or implantable devices to augment gas exchange.
Data Abstraction
Two reviewers (KB, MM) independently abstracted data and
methodological features, resolving disagreements in consultation
with a third reviewer. We contacted trial investigators for relevant
unpublished data and to obtain trial databases. Two reviewers
(KB, MM) worked together to collate data with the assistance of a
data analyst.
Validity Assessment
We assessed: allocation concealment, baseline similarity of groups
(with regard to age, severity of illness, severity of lung injury, airway
pressures, non-pulmonary organ dysfunction, and duration of hos-
pitalization); relevant cointerventions (management of acidosis, appli-
cation of positive end-expiratory pressure [PEEP], prone positioning,
inhaled nitric oxide, systemic corticosteroids, sedation and weaning
protocols), and early stopping. [18] We used the GRADE approach
to summarize the quality of evidence for each outcome. [19] In this
approach, randomized trials begin as high quality evidence but can
be rated down for apparent risk of bias, imprecision, inconsistency,
indirectness, or suspicion of publication bias.
Quantitative Data Synthesis
To assess effects of PVL on hospital mortality, we used the most
protracted follow up in each trial up to hospital discharge. We
explored as potential effect modifiers: i) incorporation of ‘open
lung’ techniques (using authors’ definitions) into experimental PVL
strategies; ii) varied thresholds for correcting respiratory acidosis;
iii) between-group gradients in tidal volumes, and airway
pressures; and iv) case mix effects. We reasoned that each of
these might influence the effect of PVL on mortality. To explore a
modifying influence of ‘open lung’ strategies, we compared pooled
effects among studies with and without ‘open lung’ strategies.
To assess tolerance for respiratory acidosis we planned 4
separate analyses and resolved to report positive findings only if
results were consistent. Two subgroup analyses assessed the effect
of different approaches to acidosis management. Trials were
classified by their pH thresholds for sodium bicarbonate
administration as either above or below (i) a clinically reasonable
pH threshold (7.25), and (ii) the mean pH threshold across trials.
In addition, we conducted 2 univariate meta-regressions [20] to
assess the impact on mortality of (i) the pH threshold at which the
assigned tidal volume or airway pressure could deviate from
protocol and (ii) mean pH thresholds across trials on mortality. For
trials that did not allow protocol deviations at pH extremes, we
assigned a pH level of 7.00.
To assess the influence of between-group gradients in tidal
volume, we conducted meta-regressions of the gradients in
assigned tidal volumes, and meta-regressions of the gradients in
tidal volumes achieved on day 1. We used the same approach to
assess the influence of variable airway pressure gradients and the
impact of having mean airway pressures in the 2 groups spanning
a threshold of 30 cm H2O. We hypothesized that treatment effects
would be greater in trials in which mean day 1 airway pressures
(ideally plateau airway pressures, if available) in the 2 groups were
on either side of 30 cm H2O.
To explore the influence of case mix, we evaluated 2 baseline
variables in separate meta-regressions: mean age and mean
baseline arterial partial pressure of oxygen/fractional concentra-
tion of inspired oxygen ratio (PaO2/FiO2). Baseline data on
plateau airway pressure were insufficiently reported to evaluate
this variable as an effect modifier. Data on the Lung Injury Score
(LIS) [21] and the Acute Physiology and Chronic Health
Evaluation (APACHE) II Score [22] were too inconsistently
reported to evaluate as effect modifiers.
To assess the effect of PVL on barotrauma we pooled trial esti-
mates of the relative risk of barotrauma, using authors’ definitions.
Wealso explored the influence of ‘open lung’ ventilation, gradients in
assigned and achieved (day1) tidal volume, and airway pressure
Lung Protective Ventilation
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study estimates of the relative risk of instituting dialysis.
We planned to evaluate the effects of PVL on duration of
mechanical ventilation and ICU and hospital length of stay.
Recognizing that early deaths systematically underestimate the
duration of these outcomes among survivors, we pooled data for
these outcomes separately among survivors and non-survivors. We
also planned sensitivity analyses to explore the influence of
weaning and sedation protocols on these outcomes.
We used random effects models [23] to pool results from each
trial (taking into consideration variation within and between trials)
and Review Manager 4.2.8 software (Cochrane Collaboration,
Oxford) to derive summary estimates of relative risk (RR) with
95% confidence intervals (CI) for binary outcomes. We formally
assessed for heterogeneity using the Cochran Q statistic [23] (with
a threshold p-value ,0.10 [24]) and the I
2 measure. [25,26] I
2
values of 0–40%, 30–60%, 50–90% and $75% represented
modest, moderate, substantial, and considerable heterogeneity,
respectively [17]. In exploring possible explanations for heteroge-
neity, we formally assessed for between-group differences in
summary estimates using the z-test for interaction. We tested for
publication bias using funnel plot analysis. We conducted meta-
regressions using SAS version 9.1 (SAS Institute, Cary, NC).
Results
Flow of Included Studies
After evaluation of 14,484 citations, 20 references were
evaluated in detail, and 10 were excluded. [27–36] Ten trials
[37–46] involving 1,749 patients met selection criteria (Figure 1).
Reviewers achieved complete agreement on trial selection and
reasons for exclusion (Table 1). For 2 trials published both in full
[39,42] and in part [34,35] both sources informed this review. We
had access to 2 complete trial databases [40,43] and 3 partial
databases. [38,39,41] We contacted several trial investigators
[37,39–46] to clarify study procedures. The lead investigator of a
foreign language publication [37] of 56 patients, not reported as
randomized, confirmed that the trial was randomized. [37].
Study Characteristics
Table 2 summarizes trial protocols. [37–46] Two trials [42,46]
were not explicitly designed to compare PVL with more traditional
strategies, but noted an incidental difference in mean tidal volume
and plateau airway pressures between groups and consequently met
criteria for inclusion. One trial [42] was designed to compare a
computer-based versus paper-based implementation of the same
PVL protocol, and the investigators observed a reduction in both
tidal volumes and airway pressures in the experimental group. The
other trial [46] compared low-stretch ventilation guided by peak or
alternatively plateau airway pressures, depending on the ventilator
mode utilized, to low tidal volume ventilation. In 2 trials, the
experimental PVL strategy (and not the control group strategy)
incorporated liberal PEEP [39] and recruitment maneuvers. [45] In
another trial [46] a liberal PEEP chart and recruitment maneuvers
were permitted in both treatment arms.
Table 3 summarizes study methods, highlighting features
related to the risk of bias. Randomization was concealed in all
Figure 1. Trials Evaluated During the Systematic Review of the Literature.
doi:10.1371/journal.pone.0014623.g001
Lung Protective Ventilation
PLoS ONE | www.plosone.org 3 January 2011 | Volume 6 | Issue 1 | e14623trials (unclear in 2) and follow up was excellent. Limitations
included lack of central randomization (3 trials), and incomplete
reporting of potentially relevant co-interventions (5 trials).
Additional threats included the necessary lack of blinding (all
trials) and stopping early for benefit (3 trials) or futility (3 trials).
Table 4 summarizes the evolution of respiratory variables in the
course of each trial, depicting actual between-groups gradients in
tidal volumes and airway pressures. Along with Table 2, this table
highlights features relevant to the generalizability of this review,
including the limits of tidal volumes and airway pressures in the
control groups. Reported mean tidal volumes in control and
pressure and volume limited groups ranged from 9.8 to 12 mL/kg
and 6.1 to 9.0 mL/kg, respectively, while the between group
gradient in achieved tidal volume ranged from 2.0 to 5.6 mL/kg
over the first week of study.
Quantitative Data Synthesis
Mortality. One trial measured ‘‘death before discharge home
and breathing without assistance’’ and reported a statistically
significant difference favoring a PVL approach (RR 0.78; 95%CI
0.65, 0.93). [43] To derive hospital mortality data from this trial,
we used individual patient data. Figure 2 illustrates individual trial
estimates of the relative risk of hospital mortality, which varied
across trials in both magnitude and direction. In 10 trials [37–46]
involving 1,749 patients we found lower hospital mortality with
PVL (RR 0.84; 95% CI 0.70, 1.00, p=0.05), with moderate
heterogeneity (I
2=43.1%, p=0.07). (Figure 2) In a sensitivity
analysis excluding 2 trials [39,45] that used ‘open lung’ strategies
(0.62; 95% CI 0.45, 0.87, p=0.005), the finding of improved
hospital mortality with PVL was attenuated (RR 0.90; 95% CI
0.74, 1.09, p=0.27), and results could not rule out the possibility
of important benefit or harm with PVL. In a post hoc sensitivity
analysis, excluding a single trial [37] stated by the authors to be
randomized but not using this descriptor in the publication, the
RR of hospital mortality using PVL was 0.86 (95% CI 0.72, 1.04;
p=0.11).
The various analyses that we conducted to assess tolerance for
acidosis with PVL strategies as an effect modifier generated
inconsistent results and were, therefore, inconclusive (data not
shown). Meta-regression analyses did not identify the magnitude of
within-study gradients in assigned (or achieved) tidal volumes or
airway pressures between treatment groups as important effect
modifiers (data not shown). We did not find a linear relationship
between study mean age or mean baseline PaO2/FiO2 and
mortality. However, these analyses were underpowered and
limited by the small number of included studies (range 3 to 9).
Barotrauma. Rates of barotrauma varied across trials from
3.8% [41] to 41.7%. [39] Pooling across 7 trials [38–43,45]
including 1,497 patients, the relative risk of barotrauma with PVL
was 0.90 (95% CI 0.66, 1.24, p=0.53) (Table 5). We found no
interaction between barotrauma effects and within-study gradients
in tidal volume or airway pressures (data not shown).
Paralysis. Five trials [38–41,43] (N=1,202) reported on the
use of paralysis. The proportion of patients receiving paralytic
agents ranged from 21.7% [40] to 74.1%. [38] Compared to
patients receiving traditional ventilation, significantly more
patients managed with a PVL approach received paralysis (RR
1.37; 95% CI, 1.04, 1.82; p=0.03).
Dialysis. Two trials [39,40] including 173 patients reported
on study initiation of dialysis. We found no effect of PVL on rates
of acute dialysis (RR 1.76 95% CI, 0.79, 3.90, p=0.16).
Table 5 applies the GRADE approach to summarize the quality of
evidence and relative and absolute estimates of effect of PVL for the 4
binary outcomes of this review (mortality, barotrauma, paralysis and
dialysis) [19]. Limitations of the evidence include methodologic
weaknesses in the studies, confidence intervals that bordered on no
effect for mortality and use of paralytic agents, and inconsistent results
for mortality. We chose to rate down the quality of evidence for
mortality primarily on the basis of inconsistency of results.
Evolution of gas exchange and organ system failure. We
provide descriptive data related to the evolution of pulmonary and
non-pulmonary organ dysfunction. While the evolution of gas
Table 1. Table of Excluded Studies.
Study
[year] Reason for Exclusion
Lee
[27]
[1990]
Included a small number of patients with ALI (14.6%).
Rappaport
[28]
[1994]
Neither compared the desired alternative approaches to ventilation nor achieved a gradient in tidal volume or airway pressure during follow-up
Carvalho
[29]
[1997]
Physiologic substudy of an included trial.
[38]
Ranieri
[30]
[1999]
Randomized trial implemented over a 40 hour study period.
Esteban
[31]
[2000]
Neither compared the desired alternative approaches to ventilation or achieved a gradient in tidal volume or airway pressure during follow-up.
Niu
[32]
[2000]
Neither compared the desired alternative approaches to ventilation or achieved a gradient in tidal volume or airway pressure during follow-up.
Long
[33]
[2006]
Neither compared the desired alternative approaches to ventilation or achieved a gradient in tidal volume or airway pressure during follow-up
McKinley
[34]
[2001]
Single centre substudy of an included larger, multicentre trial
[41].
Amato
[35]
[1995]
Preliminary data from an included trial
[38].
Wang
[36]
[2007]
Did not achieve difference between treatment groups in plateau airway pressure or tidal volumes.
doi:10.1371/journal.pone.0014623.t001
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Study
[Year]
Allocation
Concealment Baseline Similarity
a
Experimental
Cointerventions
b Sedation
c Weaning
d
Early
Stopping
e
Wu
[37]
[1998]
Sealed envelopes Not specified None Clinician
discretion
Clinician
discretion
Yes,
Futility
Brochard
[38]
1998]
Sealed envelopes Age: similar
Pulmonary injury: similar(PaO2/FiO2,L I S )
Illness severity:
similar (APACHE II
[22],S A P SI I
[47])
Nitric oxide
Frequent
but similar
Clinician
discretion
Clinician
discretion
Yes,
Futility,
ap r i o r irules
Amato
[39]
[1998]
Sealed, opaque,
sequentially
numbered
envelopes
Age: similar
Pulmonary injury: modestly favors controls
(PaO2/FiO2,L I S
[21], Static compliance)
Illness severity: similar
(APACHE II
[22],C C S
[48], organ failures)
Sepsis: favors controls
Recruitment
maneuvres
PVL group only
No others
Suggested
guideline
(sedation type;
not amount)
Suggested
guideline
Yes,
Benefit,
ap r i o r irules
Stewart
[40]
[1998]
Sealed, opaque
sequentially
numbered
envelopes
Age: similar
Pulmonary injury: modest favors controls
(PaO2/FiO2, oxygen index)
Illness severity: similar
(APACHE II
[22],M O D S
[49])
Sepsis: favors controls
No nitric oxide
No prone
positioning
Clinician
discretion
Clinician
discretion
No
Brower
[41]
[1999]
Independent
randomization
centre
Age: similar
Pulmonary injury: modestly
favors controls (PaO2/FiO2,L I S
[21])
Illness severity: similar (APACHE III
[50])
Sepsis: similar
No nitric oxide
Prone position: NA
Clinician
discretion
Clinician
discretion
Yes,
Futility,
ap r i o r irules
*East
[42]
[1999]
Independent
randomization
centre
NA None Clinician
discretion
PVL: explicit
protocol
Control: clinician
discretion
No
ARDS
Network
[43]
[2000]
Independent
randomization
centre
Age: similar
Pulmonary injury: similar (PaO2/FiO2,A R D S )
Illness severity: similar
(APACHE III
[50], organ failure)
Sepsis: similar
Prone position
Rare but similar
Others: ,1%
Clinician
discretion
Explicit
protocol
Yes,
Benefit,
ap r i o r ir u l e s
McKinley
[34]
[2001]
Independent
randomization
centre
Age: similar
Illness severity: similar (ISS
[51])
None (PVL) group Suggested
guideline
and clinician
discretion
PVL: explicit
protocol
Control: clinician
discretion
No
Orme
[44]
[2003]
Sealed, opaque,
sequentially
numbered
envelopes
NA Unknown Suggested
guideline
Explicit
protocol
No
Villar
[45]
[2006]
Sealed, opaque,
envelopes
Age: similar
Pulmonary injury: similar (LIS
[21])
Illness severity: similar (APACHE II
[22])
Sepsis: similar
NA Clinician
discretion
Clinician
discretion
Yes,
Benefit
ap r i o r ir u l e s
Sun
[46]
[2009]
Assigned
numbers,
Random
number table
Age: similar
Pulmonary injury: similar proportion
with PaO2/FiO2,200 mm Hg
Illness severity: similar(APACHE II
[22])
Sepsis: similar
No steroids or,
inhaled Nitric oxide
(both groups)
Prone position occasionally
at MD discretion
Recruitment maneuvers
(both groups)
Suggested
guideline (type,
amount, route)
Protocolized
daily awakening
Explicit Protocol
(both groups)
No
*Details obtained from a separate publication of a subgroup with trauma-induced ARDS by McKinley et al (n=67)
[34].
PVL=pressure and volume-limitation; LIS=lung injury score
[21]; APACHE II = Acute Physiology and Chronic Health Evaluation II
[22]; SAPS = simplified acute physiology
score
[47]; CCS=clinical classification score
[48]; MODS= multiple organ dysfunction score
[49]; APACHE III = Acute Physiology and Chronic Health Evaluation
[50];
ISS=illness severity score
[51]; NA=not available.
Assessment:
aBaseline similarity: Factors assessed at the time of randomization included Line 1: age; Line 2: severity of pulmonary injury (PaO2/FiO2 or LIS
[21] or A-a gradient or oxygen
index or compliance); Line 3: illness severity (APACHE II
[22] or SAPS
[47] or MODS
[49] or APACHE III
[50] or ISS
[51] and Line 4: sepsis. Each variable was assessed as similar
between treatment groups or favoring PVL or control.
bExperimental cointerventions:Line 1:Weassessedfor the use ofcorticosteroids,inhalednitricoxide,prone positioning,highfrequencyoscillation,extracorporealcirculation
and surfactant; Line 2: We described the frequency with which experimental cointerventions were utilized in each study and between treatment groups within studies.
cSedation: We characterized sedation management as guided by an explicit protocol, suggested guideline or at the discretion of clinicians.
dWeaning: We characterized weaning management as guided by an explicit protocol, suggested guideline or at the discretion of clinicians.
eEarly stopping: Line 1: We assessed for early trial termination; Line 2: We assessed whether the study stopped early for benefit or futility and Line 3We assessed for
explicit a priori stopping rules.
doi:10.1371/journal.pone.0014623.t003
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modest and inconsistent. Measurements of oxygenation over the
first week included PaO2 in 4 trials [34,38,41,43], FiO2 in 5 trials
[38,40,41,43,45] and PaO2/FiO2 ratio in 4 trials [38,39,43,45]. Of
these, 3 trials [39,43,45] noted significant differences in PaO2/FiO2
with 1 trial favoring the traditional strategy, [43] and 2 trials (using
higher PEEP) [39,45] favoring a PVL approach. One trial [34]
noted a significantly higher PaO2 favoring the non-experimental
arm. While the ARDSNet trial [43] observed lower oxygen re-
quirements among patients treated with a traditional approach,
Villar and colleagues [45] found that PVL-treated patients required
significantly lower FiO2. The latter experimental strategy, however,
included higher PEEP levels in the PVL strategy. A significantly
higher partial pressure of carbon dioxide (PaCO2) (or daily mean
PaCO2) and significantly lower pH levels (or daily mean pH) over
the first week were consistently reported with a PVL strategy in 6
trials [34,38,39,41,43,46] and 3 trials [34,39,43], respectively.
Three trials [38,43,45] evaluated organ system failures.
Brochard and colleagues [38] noted a comparable incidence of
multiple organ system failure (41%) and nonsignificant differences
in the mean number of specific failing organs at day 3, 7 and 14.
ARDS Network investigators [43] found significantly fewer days of
non-pulmonary organ system failure with PVL compared to
traditional ventilation (15611 vs. 12611; p=0.006) including
days of circulatory, coagulation or renal failure. Villar et al, [45]
found that both groups developed additional organ failures after
randomization, with patients in the control group developing
significantly more organ system failure than patients in the low
tidal volume group (p,0.001).
Data on duration of ventilation, ventilator-free days, length of
ICU and hospital stay were infrequently reported or reported non-
uniformly, which precluded meta-analysis.
Discussion
This systematic review of 10 RCTs comparing PVL strategies to
ventilation strategies designed to approach more traditional
ventilatory goals in ALI and ARDS suggests that PVL reduces
mortality. However, this finding was not robust in sensitivity
analyses and the confidence intervals include unity, so some
uncertainty remains. We did not detect dose-response interactions
between treatment effect and the magnitude the differences in tidal
volumes or airway pressures. However, control group ventilation
strategies did not achieve the full range of traditional tidal
volumes; mean tidal volumes were consistently at the lower end of
the traditional range. We found no effects of PVL ventilation on
barotrauma, which was an anticipated benefit. We observed more
acidosis with PVL strategies and a significant increase in the use of
paralytic agents.
The analysis in which we pooled survival data from trials
involving 1,749 patients may represent an overestimate of
treatment effect. The summary estimate suggests a 16.0%
reduction in the relative risk of mortality with PVL, and the
confidence intervals suggest that the relative risk of mortality might
be reduced as much as 30.0%, or not at all. While the ARDS
Network trial [43] contributed 19.9% of the weight toward this
summary estimate, the trials of Amato [39] and Villar [45]
contributed 8.8% and 9.1% weight (total 17.9% weight),
respectively. Although 3 trials [39,43,45] stopped early for benefit,
the ARDS Network trial [43] enrolled 861 patients and
contributed a large number of events (.100) in each treatment
arm, and its estimate of treatment effect is therefore unlikely to be
biased. However, the primary analysis is strongly influenced by 2
small trials that employed additional open lung strategies and
stopped early for benefit after only a small number of events (30
hospital deaths in one trial [39], and 42 in the other [45]). One
trial [39] used a correction for multiplicity proposed by Peto [52]
et al and Geller [53] et al with a significance level of ,0.001 while
the other trial [45] used a two-step stopping rule when the between
group difference in ICU mortality was $20% with at least 45
patients in each arm. Treatment effects from these trials are likely
too optimistic. While the corrections proposed for multiple
sequential analyses may control for type 1 error they cannot
Figure 2. Forest Plot of Hospital Mortality.
doi:10.1371/journal.pone.0014623.g002
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caused by early termination of small trials. [54] This issue persists
in the sensitivity analysis that excluded a single randomized trial
[37] not reported as such in the manuscript, but stated to be
randomized in discussions with the first author. The summary
estimate, excluding this trial, suggests a nonsignificant 14.0%
reduction in the relative risk of mortality with PVL, with
confidence intervals suggesting that the relative risk of mortality
might be reduced as much as 28.0% or increased by as much as
4.0%. While the ARDS Network trial [43] contributed 21.4% of
the weight toward the summary estimate of effect in this analysis,
the trials of Amato [39] and Villar [45] contributed 9.49% and
9.8% weight (total 19.3% weight), respectively.
Whether or not open lung strategies improve survival is a
subject of ongoing controversy. A recent meta-analysis of 6 RCTs
involving 2,484 patients and comparing 2 different levels of PEEP
(with or without other interventions) suggested that the use of high
levels of PEEP may have an independent beneficial effect on
mortality with an absolute risk reduction of approximately 5%.
[55] Meanwhile, empirical evidence shows that early stopping for
perceived benefit, particularly after few events, results in inflated
estimates of treatment benefits in RCTs and in subsequent meta-
analyses. [18] A sensitivity analysis excluding 2 stopped-early trials
[39,45] using PVL and an open lung approach (RR 0.90; 95% CI,
0.74, 1.09; p=0.27) was inconclusive and could not rule out the
possibility of important benefit or harm with PVL. Our results are
congruent with the lack of apparent dose-response interactions, the
lack of effect on barotrauma, and the inconsistency of study
findings with respect to rates of non-pulmonary organ dysfunction.
Historically, investigators using high tidal volumes reported high
rates of barotrauma in clinical practice. [56] The highest
barotrauma rates in this review were noted in trials that either
did not impose pressure constraints or permitted high airway
pressures. Recent epidemiologic studies in ALI and ARDS have
shown that the incidence of barotrauma is lower than in historical
series where tidal volumes were much higher. [57] However, our
pooled analysis did not detect a reduction in barotrauma with
PVL, nor did we detect an interaction with between-group
gradients in airway pressures or tidal volumes.
A notable physiological effect of PVL strategies is respiratory
acidosis. Among 6 trials reporting on the evolution of arterial
carbon dioxide levels there were significantly higher arterial partial
pressures of carbon dioxide and lower pH levels over the first week
of study. Analyses exploring a possible interaction between
tolerance for acidosis and survival effects of PVL were inconclusive.
The higher rate of paralysis with PVL strategies may be related
to higher rates of respiratory acidosis and ventilator dysynchrony.
While early observational studies suggested that neuromuscular
blockade may increase rates of ICU polyneuropathy, a recent
RCT suggested that neuromuscular blockade, itself, may improve
gas exchange and biological markers of lung injury. [58] A follow-
up trial is presently underway to evaluate the effect of paralytic
agents on ARDS mortality (NCT00299650).
Pooling results in a systematic review with meta-analysis
implicitly assumes that the trials are sufficiently similar with
respect to populations, study interventions, measurement of
outcomes and methodologic quality that one could reasonably
expect a similar underlying treatment effect. While this was our
assumption in pooling data across trials, we launched this review
with the explicit goal of testing hypotheses to explain the
differences among study results. The most prominent of the 10
trials is the ARDS Network trial [43] which enrolled more patients
than all of the other trials combined and stopped early after a
relatively large number of events, found a significant mortality
reduction with PVL and contributed the largest weight to the
pooled estimate of effect for mortality in this review. While this
trial galvanized a change in the management of ALI and ARDS,
we reviewed it in the context of all available RCT evidence
comparing the alternative approaches to ventilator management
and pooled it with other trials using conservative methods.
Strengths and Limitations
This review was strengthened by following a predetermined
protocol for review methods and statistical analysis. Our extensive
search strategy allowed us to identify an additional 341 patients
from 3 trials [37,42,46] not included in prior reviews. [13–16] We
used duplicate, independent citation screening and data abstrac-
tion. We corresponded with lead investigators for each trial. In
addition to critically appraising usual methodologic quality of
randomized trials, we also considered design characteristics
specific to this field that might lead to biased estimates of
treatment effect, most notably the confounding effects of open-
lung ventilation. Finally, based on between-study variation in
clinical protocols and statistically significant heterogeneity, we
used random effects models which take into consideration both
between-study and within-study variation for pooling data across
studies. Random effects models typically generate wider confi-
dence intervals than fixed effects models in the presence of
appreciable between-study variability in results. [59] Overall, most
trials in this review included measures to reduce bias following
randomization and were of moderate quality in reporting
important outcomes including mortality, barotrauma, paralysis,
and dialysis (see Table 5). However, heterogeneity among trials in
adopting these measures and in reporting their results may limit
interpretation of the pooled results.
Conclusion
This systematic review suggests that PVL strategies for
mechanical ventilation in ALI and ARDS may reduce mortality
and, therefore, supports the current practice to ventilate these
patients with low tidal volumes. However, we did not find a dose-
response effect and this borderline significant finding was not
robust in sensitivity analyses. Therefore, some uncertainty
regarding the effect of PVL ventilation remains.
Acknowledgments
The authors wish to express their gratitude to Drs. Roy Brower, Marcello
Amato and Laurent Brochard for providing their study databases.
Additionally, we wish to thank Dr Roy Brower for reviewing the
manuscript prior to submission.
Author Contributions
Conceived and designed the experiments: KEAB NKA ASS GG JV HZ
DC TS MOM. Performed the experiments: KEAB NKA MOM. Analyzed
the data: KEAB ASS GG JV HZ QZ DC TS MOM. Contributed
reagents/materials/analysis tools: QZ. Wrote the paper: KEAB NKA ASS
GG JV HZ QZ DC TS MOM. Designed the review protocol, conducted
the literature searches, screened abstracts and related articles, selected
studies meeting inclusion criteria, extracted data, assessed study quality,
prepared initial and subsequent drafts of the manuscript and integrated
comments from other authors into revised and final versions of the
manuscript: KEAB. Conducted the literature searches, screened abstracts,
participated in protocol design, selected studies meeting inclusion criteria,
extracted data, assessed study quality, revised and approved the final
version the manuscript: NKJA. Provided guidance in drafting the
manuscript, aided in interpreting the pooled results, and revised and
approved the final version of the manuscript: ASS DC TS. Provided
methodologic guidance in designing the protocol, drafting the manuscript,
facilitated correspondence with authors to clarify study methodology, aided
Lung Protective Ventilation
PLoS ONE | www.plosone.org 11 January 2011 | Volume 6 | Issue 1 | e14623in interpreting the pooled results, and revised and approved the final
version of the manuscript: GG. Aided in interpreting the pooled results,
assisted in preparing the manuscript, and revised and approved the final
version of the manuscript: JV. Facilitated translation of foreign language
publications and correspondence with authors to clarify study methodol-
ogy, and revised and approved the final version of the manuscript: HZ.
Provided statistical guidance for the meta-analysis, conducted the analyses
aided in interpreting the pooled results, and revised and approved the final
version of the manuscript: QZ. Designed the review protocol, screened
abstracts and related articles, adjudicated disagreements regarding study
selection and methodologic quality, provided methodologic guidance in
drafting the manuscript, prepared the evidence table, integrated comments
from other authors into revised versions of the manuscript, and revised and
approved the final version of the manuscript: MOM.
References
1. Greenfield LJ, Ebert PA, Benson DW (1964) Effect of positive pressure
ventilation on surface tension properties of lung extracts. Anesthesiology 25:
312–16.
2. Webb HH, Tierney DF (1974) Experimental pulmonary edema due to
intermittent positive pressure ventilation with high inflation pressures. Protection
by positive end-expiratory pressure. Am Rev Respir Dis 110: 556–65.
3. Kolobow T, Moretti MP, Fumagalli R, Mascheroni D, Prato P, et al. (1987)
Severe impairment in lung function induced by high peak airway pressure
during mechanical ventilation. Am Rev Respir Dis 135: 312–15.
4. Meade MO, Cook DJ (1995) The etiology, consequences, and prevention of
barotrauma: a critical review of the literature. Clin Intens Care 6: 166–73.
5. Gattinoni L, Pesenti A, Avalli L, Rossi F, Bombino M (1987) Pressure-volume
curve of total respiratory system in acute respiratory failure. Computed
tomographic scan trial. Am Rev Respir Dis 136: 730–36.
6. Hickling KG, Henderson SJ, Jackson R (1990) Low mortality associated with
low volume pressure limited ventilation with permissive hypercapnia in severe
adult respiratory distress syndrome. Intensive Care Med 16: 372–77.
7. Hickling KG, Howard R (1988) A retrospective survey of treatment and
mortality in aspiration pneumonia. Intensive Care Med 14: 617–22.
8. Hickling KG, Walsh J, Henderson S, Jackson R (1994) Low mortality rate in
adult respiratory distress syndrome using low-volume, pressure-limited ventila-
tion with permissive hypercapnia: A prospective trial. Crit Care Med 22:
1568–78.
9. Marini JJ (1994) Pressure-targeted, lung-protective ventilatory support in acute
lung injury. Chest 105 (Supp). pp 109S–14S.
10. Slutsky AS (1993) Mechanical ventilation. American College of Chest Physicians
Consensus Conference. Chest 104: 1833–59.
11. Kallet RH, Corral W, Silverman HJ, Luce JM (2001) Implementation of a low
tidal volume ventilation protocol for patients with acute lung injury or acute
respiratory distress syndrome. Respir Care 46: 1024–37.
12. Feihl F, Perret C (1994) Permissive hypercapnia: How permissive should we be?
Am J Respir Crit Care Med 150: 1722–37.
13. Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C (2002) Meta-
analysis of acute lung injury and acute respiratory distress syndrome trials tesing
low tidal volumes. Am J Respir Crit Care Med 166: 1510–14.
14. Qin ZQ, Wang C (2003) A meta-analysis of clinical studies of low volume
ventilation in ARDS. Zhonghua Yi Xue Za Zhi 83(3): 224–7.
15. Moran JL, Bersten AD, Solomon PJ (2005) Meta-analysis of controlled trials of
ventilation therapy in acute lung injury and the acute respiratory distress
syndrome: an alternative perspective. Intensive Care Med 31: 227–35.
16. Petrucci N, Iacovelli W (2007) Lung Protective Ventilation Strategy for the acute
respiratory distress syndrome. Cochrane Database of Systematic Reviews 18(3):
CD003844.
17. Higgins JPT, Green S, eds. Cochrane Handbook of Systematic Reviews of
Interventions. Version 5.0.1 [updated Sept 2008]. The Cochrane Collaboration
2008.
18. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, et al. (2005)
Randomized trials stopped early for benefit: a systematic review. JAMA 294:
2203–09.
19. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, et al. (2008) for the
GRADE working group. What is ‘‘quality of evidence’’ and why is it important
to clinicians? BMJ 336: 995–8.
20. Kleinbaum DG, Kupper LL, Muller KE (1988) Applied regression analysis and
other multivariable methods. BelmontCalif: Duxbury. pp 512–16.
21. Murray JF, Matthay MA, Luce JM, Flick JR (1988) An expanded definition of
the Acute Respiratory Distress Syndrome. Am Rev Respir Dis 134: 720–23.
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a
severity of disease classification system. Crit Care Med 13: 818–29.
23. Der Simonian R, Laird N (1986) Meta-analysis in clinical Trials. Control Clin
Trials 7: 177–88.
24. Cochran W (1954) The combination of estimates from different experiments.
Biometrics 10: 101–29.
25. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis.
Stat Med 21: 1539–58.
26. Higgins JP, Thomson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency
in meta-analyses. Brit Med J 327: 557–60.
27. Lee PC, Helsmoortel CM, Cohn SM, Fink MP (1990) Are low tidal volumes
safe? Chest 97: 425–29.
28. Rappaport SH, Shpiner R, Yoshihara G, Wright J, Chang P (1994)
Randomized, prospective trial of pressure-limited versus volume-controlled
ventilation in severe respiratory failure. Crit Care Med 22: 22–32.
29. Carvalho CRR, Barbas CSV, Medeiros DM, Magaldi RB, Filho GL, et al.
(1997) Temporal hemodynamic effects of permissive hypercapnia associated
with ideal PEEP in ARDS. Am J Respir Crit Care Med 156: 1458–66.
30. Ranieri VM, Suter PM, Tortorella C, De Tuillio R, Dayer JM, et al. (1999)
Effect of mechanical ventilation on inflammatory mediators in patients with
acute respiratory distress syndrome: a randomized controlled trial. JAMA 282:
54–61.
31. Esteban A, Alia I, Gordo F, de Pablo R, Suarez J, et al. (2000) for the Spanish
Lung Failure Collaboration Group. Prospective randomized trial comparing
pressure-controlled ventilation and volume-controlled ventilation in ARDS.
Chest 117: 1690–96.
32. Niu T, Chen T, Li P (2000) Comparison of the effects of limited airway pressure
with permissive hypercapnic ventilation and ventilation with traditional tactics in
patients suffering from acute respiratory distress syndrome. Chinese Crit Care
Med 12: 36–8.
33. Long Y, Liu DW, Zhou X, Liu HZ, Guo ZJ, et al. (2006) The application of
individualized ventilation strategies in acute respiratory distress syndrome.
Zhonghua Jie He He Hu Xi Za Zhi 29: 549–53.
34. McKinley BA, Moore FA, Sailors RM, Cocanour CS, Marquez A, et al. (2001)
Computerized decision support for mechanical ventilation of trauma induced
ARDS: results of a randomized clinical trial. J Trauma 50: 415–24.
35. Amato MB, Barbas CS, Medeiros DM, Schettino Gde P, Lorenzi Filho G, et al.
(1995) Beneficialeffectsofthe‘‘openlungapproach’’withlowdistendingpressures
in acute respiratory distress syndrome. A prospective, randomized study on
mechanical ventilation. Am J Respir Crit Care Med 152(6 Pt1): 1835–46.
36. Wang XZ, Lu CJ, Gao FQ, Li XH, Hao D, et al. (2007) Comparison of the
effects of BiPAP ventilation combined with lung recruitment maneuvers and low
tidal volume AC ventilation in patients with acute respiratory distress syndrome.
Chin J Tuberc Respir Dis 30: 44–47.
37. Wu G, Lu B (1998) The application of low tidal volume pressure-controlled
ventilation in patients with acute respiratory distress syndrome. Bull Hunan Med
Univ 23: 57–8.
38. Brochard L, Roudot-Thoraval F, Roupie E, Delclaux C, Chastre J, et al. (1998)
Tidal volume reduction for prevention of ventilator-induced lung injury in acute
respiratory distress syndrome. Am J Respir Crit Care Med 158: 1831–38.
39. Amato MB, Barbas CSV, Medeiros DM, Magaldi RB, Schettino GP, et al.
(1998) Effect of a protective-ventilation strategy on mortality in the acute
respiratory distress syndrome. N Engl J Med 338: 347–54.
40. Stewart TE, Meade MO, Cook DJ, Granton JT, Hodder RV, et al. (1998)
Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk
for acute respiratory distress syndrome. N Engl J Med 338: 355–61.
41. Brower RG, Shanholtz CB, Fessler HE, Shade DM, White P, Jr., et al. (1999)
Prospective, randomized controlled clinical trial comparing traditional versus
reduced tidal volume ventilation in acute respiratory distress syndrome patients.
Crit Care Med 27: 1492–98.
42. East TD, Heermann LK, Bradshaw RL, Lugo A, Sialors RM, et al. (1999)
Efficacy of computerized decision support for mechanical ventilation: results of a
prospective multicenter randomized trial. Proc AMIA Symp. pp 251–55.
43. (2000) The Acute Respiratory Distress Syndrome Network. Ventilation with
lower tidal volumes as compared with traditional tidal volumes for acute lung
injury and the acute respiratory distress syndrome. N Engl J Med 342: 1301–08.
44. Orme J, Jr., Romney JS, Hopkins RO, Pope D, Chan KJ, et al. (2003)
Pulmonary function and health-related quality of life in survivors of acute
respiratory distress syndrome. Am J Respir Crit Care Med 167: 690–94.
45. Villar J, Kacmarek RM, Perez-Mendez L, Aguirre-Jaime A (2006) A high
positive end-expiratory pressure, low tidal volume ventilatory strategy improves
outcome in persistent acute respiratory distress syndrome: a randomized,
controlled trial. Crit Care Med 34: 1311–18.
46. Sun J-J, Yang M-W, Wang C-H, Li C-H, Qin W-H, et al. (2009) Clinical effects
of low stretch ventilation on acute respiratory distress syndrome. Chin Crit Care
Med 21: 209–612.
47. Le Gall JR, Loirat P, Alperovitch A, Glaser P, Granthil C, et al. (1984) A
simplified acute physiology score for ICU patients. Crit Care Med 12: 975–77.
48. Cullen DJ, Civettta JM, Briggs BA, Ferrara LC (1974) Therapeutic intervention
scoring system: A method for quantitative comparison of patient care. Crit Care
Med 2: 57–60.
49. Marshall JC, Cook DK, Christou NV, Bernard GR, Sprung CL, et al. (1995)
Multiple organ dysfunction score: a reliable descriptor of a complex clinical
outcome. Crit Care Med 23: 1638–52.
50. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, et al. (1991)
The APACHE III prognostic system. Risk prediction of hospital mortality for
critically ill, hospitalized adults. Chest 100: 1619–36.
Lung Protective Ventilation
PLoS ONE | www.plosone.org 12 January 2011 | Volume 6 | Issue 1 | e1462351. Baker SP, O’Neill B, Haddon W, Jr., Long WB (1974) The Injury Severity
Score: a method for describing patients with multiple injuries and evaluation
emergency care. J Trauma 14: 187–96.
52. Peto R, Pick MC, Armitage P, Breslow NE, Cox DR, et al. (1977) Design and
analysis of randomized clinical trials requiring prolonged observation of each
patient I. Introduction and design. Br J Cancer 34: 585–612.
53. Geller NL, Pocock SJ (1987) Interim analysis in randomized clinical trials:
ramifications and guides for practitioners. Biometrics 43: 213–23.
54. Pocock SJ, Hughes MD (1990) Estimation issues in clinical trials and overviews.
Stat Med 9: 657–71.
55. Phoenix SI, Paravastu S, Columb M, Vincent JL, Nirmalan M (2009) Does a
Higher Positive End Expiratory Pressure Decrease Mortality in Acute
Respiratory Distress Syndrome? A Systematic Review and Meta-analysis.
Anesthesiology 110: 1098–1105.
56. Balk R, Bone RC (1983) The Adult Respiratory Distress Syndrome. Med Clin N
America 67: 685–700.
57. Brun-Buisson C, Minelli C, Bertolini G, Brazzi L, Pimentel J, et al. ALIVE study
Group. (2004) Epidemiology and outcome of acute lung injury in European
intensive care units. Results from the ALIVE study. Intensive Care Med 30:
51–61.
58. Gainnier M, Roch A, Forel JM, Thirion X, Arnal JM, et al. (2004) Effect of
neuromuscular blocking agents on gas exchange in patients presenting with
acute respiratory distress syndrome. Crit Care Med 32: 113–19.
59. Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI. Anti-Lymphocyte
Antibody Induction Therapy Study Group. (2002) Individual patient-versus
group-level data meta-regressions for the investigation of treatment effect
modifiers: Ecological bias rears its ugly head. Statist Med: 21: 371–87.
Lung Protective Ventilation
PLoS ONE | www.plosone.org 13 January 2011 | Volume 6 | Issue 1 | e14623